Optometrist · Harlingen, TX
NPI
1720020316
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1205 N ED Carey Dr
Harlingen, TX, 78550
Phone (956) 423-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$311K
1,781 services
Medicare patients, 2024
546
Average age 75
Drug cost, 2024
$1.3M
5,889 prescriptions
Company payments, 2025
$2,170
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rogelio Cantu Jr. was code 92012 (ophthalmological e&m), 415 times for 254 patients. In total Rogelio Cantu Jr. billed 1,781 services in 23 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 415 | 254 | $60.44 | $25K |
| 92014 Ophthalmological E&M | Office | 389 | 297 | $86.12 | $34K |
| 92134 Computerized Ophthalmic Imaging | Office | 228 | 186 | $29.44 | $6,711 |
| 65778 Eye | Office | 174 | 108 | $1,226.43 | $213K |
| 92250 Angiography | Office | 99 | 95 | $26.81 | $2,654 |
| 92083 Vision, Hearing, and Speech Services | Office | 95 | 94 | $45.35 | $4,308 |
| 92133 Computerized Ophthalmic Imaging | Office | 90 | 87 | $24.22 | $2,180 |
| 68761 Eye | Office | 67 | 62 | $148.59 | $9,956 |
| 92020 Ophthalmological E&M | Office | 63 | 62 | $19.00 | $1,197 |
| 92004 Ophthalmological E&M | Office | 51 | 51 | $92.79 | $4,732 |
| 99214 Office E&M - Established | Office | 30 | 28 | $104.60 | $3,138 |
| 92273 Test - Miscellaneous | Office | 24 | 24 | $95.08 | $2,282 |
| 92002 Ophthalmological E&M | Office | 16 | 16 | $55.39 | $886 |
| 67820 Eye | Office | 15 | 13 | $13.23 | $199 |
By year: 2022 $460K for 2,182 services; 2023 $442K for 2,010 services; 2024 $311K for 1,781 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rogelio Cantu Jr. prescribed most often to Medicare patients was Latanoprost, with 1,049 prescriptions and refills. In total Rogelio Cantu Jr. wrote 5,889 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,049 | 2,271 | 330 | $13K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 999 | 1,031 | 621 | $13K |
| Lumigan Bimatoprost | 322 | 559 | 86 | $155K |
| Ketorolac Tromethamine Generic | 295 | 505 | 142 | $15K |
| Restasis Cyclosporine | 230 | 403 | 71 | $243K |
| Cromolyn Sodium Generic | 224 | 459 | 182 | $4,774 |
| Eysuvis Loteprednol Etabonate | 222 | 271 | 93 | $154K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 218 | 516 | 78 | $4,044 |
| Flarex Fluorometholone Acetate | 206 | 243 | 74 | $41K |
| Xiidra Lifitegrast | 198 | 310 | 78 | $207K |
| Timolol Maleate Generic | 174 | 389 | 62 | $2,401 |
| Erythromycin Erythromycin Base | 151 | 181 | 92 | $2,358 |
| Cyclosporine Generic | 135 | 264 | 60 | $78K |
| Combigan Brimonidine Tartrate/Timolol | 124 | 175 | 27 | $36K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 116 | 215 | 42 | $20K |
Brand drugs: 2,482 claims; generic drugs: 3,407 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rogelio Cantu Jr. $2,170 ($2,170 in general payments such as food, travel and fees) from 14 companies. The largest payer was Bausch & Lomb Americas Inc. with $560.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 27 | $560 |
| Abbvie Inc. ABBV | 18 | $510 |
| Alcon Vision LLC ALC | 4 | $177 |
| Dompe US, Inc. | 4 | $165 |
| Harrow Eye, LLC | 1 | $148 |
| RxSight Inc RXST | 1 | $145 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $143 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $115 |
| Genentech USA, Inc. ROG.SW | 2 | $51.8 |
| Thea Pharma Inc. | 2 | $42.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.